Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 USD | -12.50% | -12.50% | +366.67% |
Evolution of the average Target Price on Silence Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Silence Therapeutics plc
Chardan Research | |
Morgan Stanley | |
BMO Capital | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- SLN Stock
- SLNCF Stock
- Consensus Silence Therapeutics plc